Filing Details
- Accession Number:
- 0001754526-23-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-23 16:23:52
- Reporting Period:
- 2023-10-19
- Accepted Time:
- 2023-10-23 16:23:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1739426 | Rvl Pharmaceuticals Plc | RVLP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754526 | Foundation Harsaul | Edificio Afra Avenida Samuel Lewis Y Calle 54 Panama R1 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2023-10-19 | 9,363,760 | $0.05 | 9,700,000 | No | 4 | S | Indirect | By Self as indirect owner of Altchem Limited |
| Ordinary Shares | Disposition | 2023-10-20 | 4,758,899 | $0.03 | 4,941,101 | No | 4 | S | Indirect | By Self as indirect owner of Altchem Limited |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Self as indirect owner of Altchem Limited |
| No | 4 | S | Indirect | By Self as indirect owner of Altchem Limited |
Footnotes
- The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0400 to $0.0580, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Represents shares of the Issuer held by Altchem Limited. Harsaul Foundation is the indirect owner of Altchem Limited. As a result, Harsaul Foundation may be deemed to share voting and investment power with respect to the shares held by Altchem Limited.
- The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0300 to $0.0373, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
